| Literature DB >> 35078440 |
Amanda I Gonzalez1, Uyen-Sa D T Nguyen2, Patricia Franklin3, Christophe Barea4, Didier Hannouche4, Anne Lübbeke4,5.
Abstract
BACKGROUND: Objectives were first to evaluate by education level one-year trajectories of pain, function and general health, as well as hospital resource and medication needs in patients undergoing primary total hip arthroplasty (THA); and second, to evaluate whether outcome differences are related to existing baseline differences in health and disease severity.Entities:
Keywords: Arthroplasty; Education; Patient reported outcomes
Mesh:
Year: 2022 PMID: 35078440 PMCID: PMC8790886 DOI: 10.1186/s12891-022-05004-6
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Fig. 1Flowchart
Patients’ characteristics prior to surgery and surgical characteristics by education level
| Characteristics | Education level | |||
|---|---|---|---|---|
| Low, | Medium, | High, | ||
| 191 (56.2) | 168 (54.9) | 149 (47.0) | 0.041 | |
| 71.0 (±10.9) | 68 (±12.6) | 64.8 (±11.7) | 0.001 | |
| Mean age men | 73.3 (±10.2) | 70.1 (±12.8) | 67.1 (±10.3) | <0.001 |
| Mean age women | 68.0 (±11.2) | 65.9 (±11.9) | 62.9 (±12.5) | 0.001 |
| <55 | 31 (9.1) | 49 (16.0) | 61 (19.2) | |
| 55-64 | 62 (18.2) | 67 (21.9) | 74 (23.3) | |
| 65-74 | 107 (31.5) | 84 (27.5) | 117 (36.9) | |
| ≥75 | 140 (41.2) | 106 (34.6) | 65 (20.5) | <0.001 |
| 28.0 (±4.9) | 26.8 (±5.3) | 25.9 (±4.4) | <0.001 | |
| <25 | 103 (30.3) | 115 (37.6) | 145 (45.7) | |
| 25-29.9 | 126 (37.1) | 116 (37.9) | 125 (39.4) | |
| 30-34.9 | 78 (22.9) | 56 (18.3) | 36 (11.4) | |
| 35-39.9 | 27 (7.9) | 15 (4.9) | 10 (3.2) | |
| ≥40 | 6 (1.8) | 4 (1.3) | 1 (0.3) | 0.001 |
| Very bad-bad | 72 (21.2) | 46 (15.0) | 32 (10.1) | |
| Good | 216 (63.7) | 177 (57.8) | 161 (50.8) | |
| Very good-excellent | 51 (15.0) | 83 (27.1) | 124 (39.1) | <0.001 |
| 1 | 22 (6.5) | 25 (8.2) | 58 (18.3) | |
| 2 | 246 (72.4) | 232 (75.8) | 234 (73.8) | |
| 3-4 | 72 (21.2) | 49 (16.0) | 25 (7.9) | <0.001 |
| 52 (15.3) | 36 (11.8) | 20 (6.3) | 0.001 | |
| 189 (55.6) | 162 (52.9) | 121 (38.2) | <0.001 | |
| 21 (6.2) | 21 (6.9) | 14 (4.4) | 0.401 | |
| A | 109 (32.1) | 109 (35.6) | 107 (33.8) | |
| B | 56 (16.5) | 62 (20.3) | 87 (27.4) | |
| C | 175 (51.5) | 134 (43.8) | 123 (38.8) | 0.006 |
| Never smoker | 204 (60.0) | 184 (60.3) | 188 (59.5) | |
| Ever smoker | 136 (40.0) | 121 (39.7) | 128 (40.5) | 0.977 |
| Primary osteoarthritis | 304 (89.4) | 276 (90.2) | 271 (85.5) | |
| Secondary osteoarthritis | 36 (10.6) | 30 (9.8) | 46 (14.5) | 0.141 |
| 188 (55.3) | 169 (55.2) | 176 (55.5) | 0.997 | |
| Acetaminophen | 73 (21.5) | 75 (24.5) | 66 (20.8) | 0.497 |
| NSAIDs | 119 (35.0) | 122 (39.9) | 143 (45.1) | 0.030 |
| Opioids | 59 (17.4) | 40 (13.1) | 43 (13.6) | 0.238 |
| Private | 8 (2.4) | 25 (8.2) | 97 (30.6) | |
| Public | 332 (97.6) | 281 (91.8) | 220 (69.4) | <0.001 |
| Anterior | 302 (87.6) | 268 (87.6) | 275 (86.8) | |
| Lateral | 15 (4.4) | 11 (3.6) | 19 (6.0) | |
| Other | 23 (6.8) | 27 (8.8) | 23 (7.3) | 0.551 |
| Uncemented | 248 (72.9) | 231 (75.5) | 256 (80.8) | |
| Hybrid | 85 (250) | 68 (22.2) | 58 (6.0) | |
| Cemented | 7 (2.1) | 7 (2.3) | 3 (0.9) | 0.160 |
| Ceramic-on-highly cross-linked polyethylene | 326 (95.9) | 284 (92.8) | 295 (93.1) | |
| Other | 14 (4.1) | 22 (7.2) | 22 (6.9) | 0.184 |
*p value for continuous variable calculated with t-test or ANOVA test, p value for categorical variables calculated with Pearson chi-square
#One patients had missing information on self-rated health and 2 patients had missing information on smoking status
Patient-reported outcomes (PROs) preoperative and 1-year postoperative by education level
| Education | |||
|---|---|---|---|
| Low | Medium | High | |
| Preoperative | 36.0 (18.6) | 39.2 (16.0) | 43.8 (17.1) |
| 1-year postoperative | 84.3 (19.1) | 87.6 (17.3) | 89.6 (16.4) |
| Gain | 48.3 (23.3) | 48.4 (20.3) | 45.9 (19.2) |
| Effect size, Cohen’s d | 2.6 | 2.9 | 2.7 |
| Preoperative | 36.2 (19.1) | 39.7 (17.7) | 45.5 (16.9) |
| 1-year postoperative | 76.3 (22.8) | 82.0 (19.7) | 85.6 (17.1) |
| Gain | 40.1 (24.8) | 42.2 (22.1) | 40.1 (20.0) |
| Effect size, Cohen’s d | 1.9 | 2.3 | 2.4 |
| Preoperative | 33.1 (7.6) | 33.9 (7.4) | 34.3 (7.9) |
| 1-year postoperative | 42.9 (9.3) | 45.6 (9.5) | 47.1 (9.5) |
| Gain | 9.8 (10.2) | 11.7 (10.0) | 12.8 (10.6) |
| Effect size, Cohen’s d | 1.2 | 1.4 | 1.5 |
| Preoperative | 41.9 (11.5) | 44.7 (10.6) | 47.5 (10.3) |
| 1-year postoperative | 46.4 (11.1) | 48.5 (9.8) | 49.2 (10.0) |
| Gain | 4.6 (11.4) | 3.8 (10.2) | 1.7 (10.3) |
| Effect size, Cohen’s d | 0.5 | 0.4 | 0.2 |
Fig. 2Preoperative and postoperative scores for the education groups
Patient reported outcomes (PROs) 1-year after total hip arthroplasty by education level
| Unadjusted | Adjusted | |||
|---|---|---|---|---|
| β coefficient with 95% confident interval | β coefficient with 95% confident interval | |||
| Low | -5.4 (-8.1 to -2.7) | <0.001 | -2.5 (-5.2 to 0.2) | 0.071 |
| Medium | -2.0 (-4.8 to 0.8) | 0.154 | -0.6 (-3.3 to 2.1) | 0.653 |
| High | Reference | Reference | ||
| Low | -9.0 (-12.1 to -5.9) | <0.001 | -2.6 (-5.7 to 0.5) | 0.098 |
| Medium | -4.1 (-7.3 to -0.9) | 0.012 | -0.1 (-3.1 to 2.9) | 0.950 |
| High | Reference | Reference | ||
| Low | -4.2 (-5.7 to -2.7) | <0.001 | -1.9 (-3.3 to -0.5) | 0.009 |
| Medium | -1.6 (-3.1 to -0.1) | 0.037 | 0.2 (-1.6 to 1.2) | 0.760 |
| High | Reference | Reference | ||
| Low | -2.7 (-4.3 to -1.1) | 0.001 | -0.1 (-1.6 to 1.5) | 0.949 |
| Medium | -0.8 (-2.4 to 0.9) | 0.368 | 0.7 (-0.8 to 2.2) | 0.343 |
| High | Reference | Reference | ||
aAdjustment performed for corresponding preoperative PRO level, sex, ASA score, type of osteoarthritis, Charnley classification, age, BMI, and self-rated health (for WOMAC Pain and Function only)
Hospital resources use and medication need
| Education level | ||||
|---|---|---|---|---|
| Low | Medium | High | ||
| 7.6 (±3.5) | 7.2 (±3.1) | 6.6 (±3.0) | 0.001 | |
| Home | 223 (65.6) | 212 (69.3) | 264 (83.3) | |
| Rehabilitation | 117 (34.4) | 94 (30.7) | 53 (16.7) | <0.001 |
| 315 (92.6) | 280 (91.5) | 293 (92.4) | 0.850 | |
| Acetaminophen | 294 (86.5) | 271 (88.6) | 276 (87.1) | 0.716 |
| NSAIDs | 148 (43.5) | 157 (51.3) | 171 (53.9) | 0.21 |
| Opioid | 25 (7.4) | 30 (9.8) | 28 (8.8) | 0.534 |
| 149 (43.8) | 105 (34.3) | 98 (30.9) | 0.002 | |
| Acetaminophen | 102 (30.0) | 75 (24.5) | 59 (18.6) | 0.003 |
| NSAIDs | 56 (16.5) | 44 (14.4) | 57 (18.0) | 0.474 |
| Opioid | 31 (9.1) | 12 (3.9) | 13 (4.1) | 0.005 |
*p value for continuous variable calculated with ANOVA and for categorical variables calculated with Pearson Chi-Square